Export

EN
FR
Valganciclovir
Essential medicine status
Section:
6. Anti-infective medicines 6.4. Antiviral medicines 6.4.3. Other antivirals
ATC codes: J05AB14
EMLc
Indication
Cytomegaloviral retinitis ICD11 code: 9B72.00
INN
Valganciclovir
Medicine type
Chemical agent
List type
Core (EML)
Complementary (EMLc)
Formulations
Oral > Liquid: 50 mg per mL (as hydrochloride) powder for oral solution (EMLc)
Oral > Solid > tablet: 450 mg (as hydrochloride)
EML status history
First added in 2015 (TRS 994)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Valganciclovir
DrugBank
Valganciclovir
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - to modify the formulation descriptions to better describe the available dosage forms.